10-Q Filing

CELLDEX THERAPEUTICS, INC. CIK: 744218 Q2 2011

Filing Information

Form Type	10-Q
Accession Number	`0001104659-11-043630`
Period End Date	20110630
Filing Date	20110804
Fiscal Year	2011
Fiscal Period	Q2
XBRL Instance	cldx-20110630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 71 Income Statement 64 Cash Flow Statement 62

Balance Sheet 71 line items

Line Item	Tag	Value	Unit	Period
Convertible Preferred Stock, Par Value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Convertible Preferred Stock, Par Value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Convertible Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Convertible Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Convertible Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Convertible Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Convertible Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Convertible Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$57.00M	USD	Point-in-time
Common Stock, Par Value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$10.83M	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$21.29M	USD	Point-in-time
Common Stock, Par Value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$15.16M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	297.00M	shares	Point-in-time
Marketable Securities	`MarketableSecuritiesCurrent`	$60.41M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	297.00M	shares	Point-in-time
Marketable Securities	`MarketableSecuritiesCurrent`	$39.81M	USD	Point-in-time
Accounts and Other Receivables	`AccountsAndOtherReceivablesNetCurrent`	$163.00K	USD	Point-in-time
Accounts and Other Receivables	`AccountsAndOtherReceivablesNetCurrent`	$324.00K	USD	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	44.15M	shares	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	32.06M	shares	Point-in-time
Prepaid and Other Current Assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.89M	USD	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	44.15M	shares	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	32.06M	shares	Point-in-time
Prepaid and Other Current Assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.52M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$62.95M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$73.29M	USD	Point-in-time
Property and Equipment, Net	`PropertyPlantAndEquipmentNet`	$10.83M	USD	Point-in-time
Property and Equipment, Net	`PropertyPlantAndEquipmentNet`	$9.98M	USD	Point-in-time
Intangible Assets, Net	`IntangibleAssetsNetExcludingGoodwill`	$25.87M	USD	Point-in-time
Intangible Assets, Net	`IntangibleAssetsNetExcludingGoodwill`	$26.84M	USD	Point-in-time
Other Assets	`OtherAssetsNoncurrent`	$367.00K	USD	Point-in-time
Other Assets	`OtherAssetsNoncurrent`	$363.00K	USD	Point-in-time
Goodwill	`Goodwill`	$8.96M	USD	Point-in-time
Goodwill	`Goodwill`	$8.96M	USD	Point-in-time
Total Assets	`Assets`	$118.48M	USD	Point-in-time
Total Assets	`Assets`	$109.94M	USD	Point-in-time
Accounts Payable	`AccountsPayableCurrent`	$931.00K	USD	Point-in-time
Accounts Payable	`AccountsPayableCurrent`	$514.00K	USD	Point-in-time
Accrued Expenses	`AccruedLiabilitiesCurrent`	$4.94M	USD	Point-in-time
Accrued Expenses	`AccruedLiabilitiesCurrent`	$4.42M	USD	Point-in-time
Current Portion of Long-Term Liabilities	`OtherLiabilitiesCurrent`	$818.00K	USD	Point-in-time
Current Portion of Long-Term Liabilities	`OtherLiabilitiesCurrent`	$479.00K	USD	Point-in-time
Current Portion of Term Loan	`SecuredDebtCurrent`	$1.11M	USD	Point-in-time
Current Portion of Term Loan	`SecuredDebtCurrent`	$5.00M	USD	Point-in-time
Convertible Subordinated Debt	`ConvertibleSubordinatedDebtCurrent`	$12.41M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$20.21M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$10.41M	USD	Point-in-time
Term Loan, less Current Portion	`SecuredLongTermDebt`	$8.89M	USD	Point-in-time
Term Loan, less Current Portion	`SecuredLongTermDebt`	$10.07M	USD	Point-in-time
Other Long-Term Liabilities	`OtherLiabilitiesNoncurrent`	$5.99M	USD	Point-in-time
Other Long-Term Liabilities	`OtherLiabilitiesNoncurrent`	$5.59M	USD	Point-in-time
Total Liabilities	`Liabilities`	$26.47M	USD	Point-in-time
Total Liabilities	`Liabilities`	$34.69M	USD	Point-in-time
Commitments and Contingent Liabilities	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingent Liabilities	`CommitmentsAndContingencies`	-	USD	Point-in-time
Convertible Preferred Stock, $.01 Par Value; 3,000,000 Shares Authorized; No Shares Issued and Outstanding at June 30, 2011 and December 31, 2010	`PreferredStockValue`	-	USD	Point-in-time
Convertible Preferred Stock, $.01 Par Value; 3,000,000 Shares Authorized; No Shares Issued and Outstanding at June 30, 2011 and December 31, 2010	`PreferredStockValue`	-	USD	Point-in-time
Common Stock, $.001 Par Value; 297,000,000 Shares Authorized; 44,147,214 and 32,055,382 Shares Issued and Outstanding at June 30, 2011 and December 31, 2010, respectively	`CommonStockValue`	$44.00K	USD	Point-in-time
Common Stock, $.001 Par Value; 297,000,000 Shares Authorized; 44,147,214 and 32,055,382 Shares Issued and Outstanding at June 30, 2011 and December 31, 2010, respectively	`CommonStockValue`	$32.00K	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$269.69M	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$232.68M	USD	Point-in-time
Accumulated Other Comprehensive Income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$2.77M	USD	Point-in-time
Accumulated Other Comprehensive Income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$2.75M	USD	Point-in-time
Accumulated Deficit	`RetainedEarningsAccumulatedDeficit`	$-180.50M	USD	Point-in-time
Accumulated Deficit	`RetainedEarningsAccumulatedDeficit`	$-160.21M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.25M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$92.00M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$109.94M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$118.48M	USD	Point-in-time

Income Statement 64 line items

Line Item	Tag	Value	Unit	Period
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$25.00K	USD	2 Qtrs
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$2.75M	USD	2 Qtrs
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$11.00K	USD	1 Quarter
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$1.40M	USD	1 Quarter
Contracts and Grants	`RevenueFromContractsAndGrants`	$220.00K	USD	2 Qtrs
Contracts and Grants	`RevenueFromContractsAndGrants`	-	USD	1 Quarter
Product Royalties	`RoyaltyRevenue`	$1.94M	USD	1 Quarter
Product Royalties	`RoyaltyRevenue`	$4.44M	USD	2 Qtrs
Product Royalties	`RoyaltyRevenue`	$1.55M	USD	1 Quarter
Product Royalties	`RoyaltyRevenue`	$3.70M	USD	2 Qtrs
Total Revenue	`Revenues`	$1.95M	USD	1 Quarter
Total Revenue	`Revenues`	$2.95M	USD	1 Quarter
Total Revenue	`Revenues`	$6.66M	USD	2 Qtrs
Total Revenue	`Revenues`	$4.47M	USD	2 Qtrs
Research and Development	`ResearchAndDevelopmentExpense`	$7.26M	USD	1 Quarter
Research and Development	`ResearchAndDevelopmentExpense`	$7.17M	USD	1 Quarter
Research and Development	`ResearchAndDevelopmentExpense`	$13.69M	USD	2 Qtrs
Research and Development	`ResearchAndDevelopmentExpense`	$14.02M	USD	2 Qtrs
Royalty	`RoyaltyExpense`	$4.06M	USD	2 Qtrs
Royalty	`RoyaltyExpense`	$1.73M	USD	1 Quarter
Royalty	`RoyaltyExpense`	$1.94M	USD	1 Quarter
Royalty	`RoyaltyExpense`	$4.44M	USD	2 Qtrs
General and Administrative	`GeneralAndAdministrativeExpense`	$5.43M	USD	2 Qtrs
General and Administrative	`GeneralAndAdministrativeExpense`	$2.24M	USD	1 Quarter
General and Administrative	`GeneralAndAdministrativeExpense`	$4.63M	USD	2 Qtrs
General and Administrative	`GeneralAndAdministrativeExpense`	$2.59M	USD	1 Quarter
Gain on Sale of Assets	`GainLossOnDispositionOfAssets`	-	USD	1 Quarter
Gain on Sale of Assets	`GainLossOnDispositionOfAssets`	$50.00K	USD	2 Qtrs
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$483.00K	USD	1 Quarter
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$2.18M	USD	2 Qtrs
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$658.00K	USD	1 Quarter
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$966.00K	USD	2 Qtrs
Total Operating Expense	`CostsAndExpenses`	$24.01M	USD	2 Qtrs
Total Operating Expense	`CostsAndExpenses`	$25.36M	USD	2 Qtrs
Total Operating Expense	`CostsAndExpenses`	$12.24M	USD	1 Quarter
Total Operating Expense	`CostsAndExpenses`	$11.83M	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-9.88M	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-18.69M	USD	2 Qtrs
Operating Loss	`OperatingIncomeLoss`	$-19.54M	USD	2 Qtrs
Operating Loss	`OperatingIncomeLoss`	$-9.29M	USD	1 Quarter
Investment and Other Income, Net	`NonoperatingIncomeExpense`	$163.00K	USD	2 Qtrs
Investment and Other Income, Net	`NonoperatingIncomeExpense`	$3.26M	USD	2 Qtrs
Investment and Other Income, Net	`NonoperatingIncomeExpense`	$95.00K	USD	1 Quarter
Investment and Other Income, Net	`NonoperatingIncomeExpense`	$79.00K	USD	1 Quarter
Interest Expense	`InterestExpense`	$671.00K	USD	2 Qtrs
Interest Expense	`InterestExpense`	$334.00K	USD	1 Quarter
Interest Expense	`InterestExpense`	$434.00K	USD	1 Quarter
Interest Expense	`InterestExpense`	$920.00K	USD	2 Qtrs
Net Loss	`ProfitLoss`	$-20.30M	USD	2 Qtrs
Net Loss	`ProfitLoss`	$-9.53M	USD	1 Quarter
Net Loss	`ProfitLoss`	$-16.11M	USD	2 Qtrs
Net Loss	`ProfitLoss`	$-10.24M	USD	1 Quarter
Basic and Diluted Net Loss Per Common Share (Note 4) (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.27	USD	1 Quarter
Basic and Diluted Net Loss Per Common Share (Note 4) (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.51	USD	2 Qtrs
Basic and Diluted Net Loss Per Common Share (Note 4) (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.30	USD	1 Quarter
Basic and Diluted Net Loss Per Common Share (Note 4) (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.58	USD	2 Qtrs
Shares Used in Calculating Basic Net Loss per Share (Note 4) (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	31.75M	shares	2 Qtrs
Shares Used in Calculating Basic Net Loss per Share (Note 4) (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	37.46M	shares	1 Quarter
Shares Used in Calculating Basic Net Loss per Share (Note 4) (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	34.77M	shares	2 Qtrs
Shares Used in Calculating Basic Net Loss per Share (Note 4) (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	31.82M	shares	1 Quarter
Shares Used in Calculating Diluted Net Loss per Share (Note 4) (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	31.82M	shares	1 Quarter
Shares Used in Calculating Diluted Net Loss per Share (Note 4) (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	34.77M	shares	2 Qtrs
Shares Used in Calculating Diluted Net Loss per Share (Note 4) (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	31.75M	shares	2 Qtrs
Shares Used in Calculating Diluted Net Loss per Share (Note 4) (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	37.46M	shares	1 Quarter

Cash Flow Statement 62 line items

Line Item	Tag	Value	Unit	Period
Net Loss	`ProfitLoss`	$-20.30M	USD	2 Qtrs
Net Loss	`ProfitLoss`	$-9.53M	USD	1 Quarter
Net Loss	`ProfitLoss`	$-16.11M	USD	2 Qtrs
Net Loss	`ProfitLoss`	$-10.24M	USD	1 Quarter
Depreciation and Amortization	`DepreciationDepletionAndAmortization`	$1.13M	USD	2 Qtrs
Depreciation and Amortization	`DepreciationDepletionAndAmortization`	$1.61M	USD	2 Qtrs
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$483.00K	USD	1 Quarter
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$2.18M	USD	2 Qtrs
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$658.00K	USD	1 Quarter
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$966.00K	USD	2 Qtrs
Amortization and Premium of Marketable Securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$242.00K	USD	2 Qtrs
Amortization and Premium of Marketable Securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$520.00K	USD	2 Qtrs
Realized Loss on Sales and Maturities of Marketable Securities	`MarketableSecuritiesGainLoss`	$-31.00K	USD	2 Qtrs
Realized Loss on Sales and Maturities of Marketable Securities	`MarketableSecuritiesGainLoss`	$-8.00K	USD	2 Qtrs
(Gain) Loss on Sale or Disposal of Assets	`GainLossOnSaleOfPropertyPlantEquipment`	$55.00K	USD	2 Qtrs
(Gain) Loss on Sale or Disposal of Assets	`GainLossOnSaleOfPropertyPlantEquipment`	$-38.00K	USD	2 Qtrs
Stock-Based Compensation Expense	`ShareBasedCompensation`	$1.61M	USD	2 Qtrs
Stock-Based Compensation Expense	`ShareBasedCompensation`	$1.13M	USD	2 Qtrs
Non-Cash Interest Expense	`AmortizationOfDebtDiscountPremium`	$364.00K	USD	2 Qtrs
Non-Cash Interest Expense	`AmortizationOfDebtDiscountPremium`	$192.00K	USD	2 Qtrs
Accounts and Other Receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-161.00K	USD	2 Qtrs
Accounts and Other Receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$194.00K	USD	2 Qtrs
Prepaid and Other Current Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$408.00K	USD	2 Qtrs
Prepaid and Other Current Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$702.00K	USD	2 Qtrs
Other Assets	`IncreaseDecreaseInOtherOperatingAssets`	$-373.00K	USD	2 Qtrs
Other Assets	`IncreaseDecreaseInOtherOperatingAssets`	$4.00K	USD	2 Qtrs
Accounts Payable and Accrued Expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-937.00K	USD	2 Qtrs
Accounts Payable and Accrued Expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-1.85M	USD	2 Qtrs
Deferred Revenue	`IncreaseDecreaseInDeferredRevenue`	$-2.04M	USD	2 Qtrs
Other Long-Term Liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-1.41M	USD	2 Qtrs
Other Long-Term Liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$122.00K	USD	2 Qtrs
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-16.61M	USD	2 Qtrs
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-18.23M	USD	2 Qtrs
Sales and Maturities of Marketable Securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$19.25M	USD	2 Qtrs
Sales and Maturities of Marketable Securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$18.39M	USD	2 Qtrs
Purchases of Marketable Securities	`PaymentsToAcquireMarketableSecurities`	$43.88M	USD	2 Qtrs
Purchases of Marketable Securities	`PaymentsToAcquireMarketableSecurities`	$38.73M	USD	2 Qtrs
Acquisition of Property and Equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$282.00K	USD	2 Qtrs
Acquisition of Property and Equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.13M	USD	2 Qtrs
Proceeds from Sale or Disposal of Assets	`ProceedsFromSaleOfProductiveAssets`	$64.00K	USD	2 Qtrs
Net Cash Used in Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$-20.55M	USD	2 Qtrs
Net Cash Used in Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$-25.75M	USD	2 Qtrs
Net Proceeds from Stock Issuances	`ProceedsFromIssuanceOfCommonStock`	$35.89M	USD	2 Qtrs
Net Proceeds from Stock Issuances	`ProceedsFromIssuanceOfCommonStock`	$616.00K	USD	2 Qtrs
Issuance of Term Loan	`ProceedsFromIssuanceOfLongTermDebt`	$5.00M	USD	2 Qtrs
Payment of Convertible Subordinated Debt	`RepaymentsOfSubordinatedDebt`	$12.50M	USD	2 Qtrs
Payments of Other Long-Term Liabilities	`RepaymentsOfOtherLongTermDebt`	$58.00K	USD	2 Qtrs
Payments of Other Long-Term Liabilities	`RepaymentsOfOtherLongTermDebt`	$94.00K	USD	2 Qtrs
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$522.00K	USD	2 Qtrs
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$28.33M	USD	2 Qtrs
Effect of Exchange Rate Changes on Cash and Cash Equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-5.00K	USD	2 Qtrs
Effect of Exchange Rate Changes on Cash and Cash Equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$1.00K	USD	2 Qtrs
Net Decrease in Cash and Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-10.46M	USD	2 Qtrs
Net Decrease in Cash and Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-41.84M	USD	2 Qtrs
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$57.00M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$10.83M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$21.29M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$15.16M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$57.00M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$10.83M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$21.29M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$15.16M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.